33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Durability of response with larotrectinib in adult and pediatric patients with TRK fusion cancer
    Meeting Abstract

    Leyvraz, S.; Hyman, D. M.; van Tilburg, C. M.; Albert, C. M.; Tan, D. S.; Geoerger, B.; Farago, A. F.; Laetsch, T. W.; Kummar, S.; Doz, F.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • BEACON CRC: A randomized, phase 3 study of encorafenib (ENCO) and cetuximab (CETUX) with or without binimetinib (BiNI) vs. choice of either irinotecan or folfiri plus cetux in BRAF V600E-mutant metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Vogel, A.; Hegewisch-Becker, S.; Prager, G.; Folprecht, G.; Stahl, M.; Kopetz, S.; Grothey, A.; van Cutsetn, E.; Yaeger, R.; Wasan, H.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Association of adverse events (AES) with efficacy outcomes for cabozantinib (C) in patients (PTS) with advanced hepatocellular carcinoma (AHCC) in the phase 3 CELESTIAL trial
    Meeting Abstract

    Waidmann, O.; Abou-Alfa, G. K.; Meker, T.; Cheng, A. L.; Cicin, I.; Bolondi, L.; Klumpem, H. J.; Chan, S. L.; Dadduzio, V.; Milwee, S.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Quality-adjusted life years accrued with cabozantinib in patients with advanced hepatocellular carcinoma (AHCC) in the CELESTIAL trial
    Meeting Abstract

    Venerito, M.; Abou-Alfa, G. K.; Mollon, P.; Meyer, T.; Cheng, A. L.; El-Khoueiry, A. B.; Kelley, R. K.; Baron, A. D.; Benzaghou, F.; Valcheva, V.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Efficacy of entrectinib in patients (PTS) with solid tumors and central nervous system (CNS) metastases: Integrated analysis from 3 clinical trials
    Meeting Abstract

    Overbeck, T.; Siena, S.; Doebele, R. C.; Shaw, A. T.; Karapetis, C. C.; Tan, D. S. W.; Cho, B. C.; Kim, D. W.; Ahn, M. J.; Krebs, M. G.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Matching-adjusted indirect comparison of cabozantinib (C) versus regorafenib (R) in advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Venerito, M.; Kelley, R. K.; Mollon, P.; Blanc, J. F.; Daniele, B.; Yau, T.; Cheng, A. L.; Valcheva, V.; Remiro Azocar, A.; Baio, G.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Recurrent chromatin remodeling pathway mutations identified in ovarian juvenile granulosa cell tumors
    Meeting Abstract

    Vougiouklakis, T.; Vasudevaraja, V.; Shen, G.; Feng, X.; Chiang, S.; Barroeta, J.; Thomas, K.; Schwartz, L.; Linn, R.; Oliva, E.; more...
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • International endocervical adenocarcinoma criteria and classification (IECC): An independent cohort with clinical and molecular relevance
    Meeting Abstract

    Ren, H.; Almadani, N.; Pors, J.; Ho, J. L.; Chow, C.; Park, K.; Stolnicu, S.; Soslow, R.; Huntsman, D.; Gilks, C. B.; more...
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • Three-dimensional vessel extraction in whole block imaging using deep neural networks
    Meeting Abstract

    Ohnishi, T.; Teplov, A.; Kawata, N.; Stueben, B.; Ibrahim, K.; Ntiamoah, P.; Firat, C.; Haneishi, H.; Hameed, M.; Shia, J.; more...
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • Head and neck (H&N) malignant mesenchymal neoplasms with GLI1 gene alterations: A pathologic entity with distinct histologic features and potential for distant metastasis
    Meeting Abstract

    Xu, B.; Chang, K.; Folpe, A.; Kao, Y. C.; Wey, S. L.; Huang, H. Y.; Rooper, L.; Bishop, J.; Dickson, B.; Lee, J. C.; more...
    Modern Pathology (2020)

    Fulltext@MSK | Save